Drug marketing practices come under scrutinyBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7456.10-a (Published 01 July 2004) Cite this as: BMJ 2004;329:10
- Fred Charatan
Federal prosecutors have issued subpoenas to several drug makers, including Johnson and Johnson, Wyeth, and Bristol-Myers Squibb, as part of an investigation from Boston, Massachusetts, into a pattern of financial incentives that the major drug makers have used to persuade doctors to favour their drugs.
The action comes after a number of doctors revealed the ploys allegedly adopted by the various …
Log in using your username and password
Log in through your institution
Sign up for a free trial